Wednesday, October 8, 2025

Latest

Consensus Estimates For Amazon’s First Quarter Of 2021

Amazon.com Inc (NASDAQ: AMZN) will be reporting its first quarter financial results on April 29th after market close. Analysts have a consensus $3,993.18 12-month price target on the company, via a total of 47 analysts, with 18 analysts having strong buy ratings. 27 analysts meanwhile have buy ratings and, two analysts have hold ratings. The street high comes from Susquehanna Financial with a $5,200 price target, and the lowest target sits at $3,048 from R5 Capital.

36 analysts have revenue estimates for the first quarter. The mean revenue estimate between all 36 analysts is $104.46 billion; this number has been revised upwards from $95.31 billion at the start of the year. The highest revenue estimate is $107.5 billion, while the lowest is $99.5 billion.

The analyst consensus for net income for the first quarter is $4.96 billion, this is up from the start of the year which was $4.79 billion. The highest net income estimate is $6.14 billion, while the lowest is $3.3 billion.

Onto EBITDA estimates, there are currently 26 analysts who have first-quarter EBITDA estimates. The mean is currently $15.84 billion, with this number having been revised up from $14.84 billion at the start of the year. The street high estimate currently sits at $18 billion in EBITDA and the lowest is $14.13 billion.

Analysts estimate that quarterly earnings per share will come in at $9.54, with this number being slightly revised up from $9.04 at the start of the year. Street high is $12.00 and the lowest estimate is $6.41 per share for the quarter.


Video Articles

Fortune Bay: The Potential Billion Dollar Project

Japan Gold Enters New Chapter as Barrick Alliance Concludes – John Proust

Barrick Mining’s “Company Defining [Gold] Discovery”

Recommended

Nord Precious Metals Produces High Grade Silver Concentrate From Tailings

ESGold Secures $9 Million In Non-Dilutive Funding From Ocean Partners

Related News

Else Nutrition: Canaccord Cuts Target To $2.00 After Financing

On June 22, Else Nutrition (TSX: BABY) announced that it raised $7.29 million by selling...

Monday, July 4, 2022, 04:33:00 PM

MediPharm Labs: Canaccord Resumes Coverage, Issues $2.25 Price Target

As a follow up to the earlier covered resumption of coverage by Canaccord Genuity on...

Monday, July 6, 2020, 04:53:00 PM

Canaccord Upgrades Valens Company Price Target Following US Entrance

The Valens Company (TSX: VLNS) was very busy over the course of the last week....

Sunday, May 2, 2021, 11:44:00 AM

SNAP Sees Consensus Price Target To $12.47 After Q3 Results

Snap Inc (NYSE: SNAP) on Friday reported its third-quarter financial results. The company announced revenues...

Sunday, October 23, 2022, 03:20:00 PM

Canaccord Drops Antibe’s Price Target To $0.70 Following Asset Sale

Antibe Therapeutics Inc. (TSX: ATE) recently reported their full-year 2022 results, wherein the company reported...

Friday, July 15, 2022, 02:25:00 PM